International study on etiology of inhibitors in patients with a moderate or mild form of hemophilia A, influences of immunogenetic and hemophilia treatment factors.
- Conditions
- stollingsstoornissenhemophilia Ableeding disorder
- Registration Number
- NL-OMON32171
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
mild/moderate hemophilia A (factor VIII 2-40%)
Exclusion Criteria
severe hemophilia A (factor VIII <2%)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method